financetom
Business
financetom
/
Business
/
Adani open offer sees 28 lakh NDTV shares tendered by Day 3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Adani open offer sees 28 lakh NDTV shares tendered by Day 3
Nov 24, 2022 11:08 AM

The Adani group's open offer to acquire an additional 26 percent stake in the media firm New Delhi Television (NDTV) saw nearly 28 lakh shares being tendered by NDTV shareholders at the end Day 3 on Thursday, November 24. According to the data from the BSE, a total of 27,72,159 NDTV shares — amounting to 16.54 percent of the offer size — were tendered by 4 pm on Thursday.

Share Market Live

NSE

The Adanis' offer price is Rs 294 per share, while NDTV shares settled at Rs 368.40 on Thursday, which is 25.3 percent higher than the offer price. In the last three months, NDTV shares reached a high of Rs 540.85 on September 5, 2022.

The offer closes on December 5, a notice by JM Financial, the firm managing the offer on behalf of Adani Group firms, said. Markets regulator SEBI on November 7 granted its approval to the proposed Rs 492.81-crore open offer.

The conglomerate, run by India's richest man Gautam Adani, in August acquired a little-known company that lent over Rs 400 crore to NDTV's founders more than a decade ago in exchange for warrants that allowed the company to acquire a stake of 29.18 percent in the news group at any time.

Also read: From Harsha Engineers to Adani Wilmar to LIC: Here's a look at the most to least chased IPOs of 2022

Post that, VCPL – the firm that the Adani group bought out – announced that it would launch an open offer on October 17 to buy an additional 26 percent stake from minority shareholders of NDTV. However, the offer was delayed since SEBI had not given its approval to the open offer. VCPL, along with AMG Media Networks and Adani Enterprises Ltd, had proposed to acquire an additional 26 percent, or 1.67 crore equity shares, at an offer price of Rs 294 per share.

If fully subscribed, the open offer will amount to Rs 492.81 crore at a price of Rs 294 per share. On Thursday, shares of NDTV closed at Rs 368.40 on BSE, up 2.65 percent from November 23.

(Edited by : Shoma Bhattacharjee)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved